The agency approved Biogen’s Aduhelm “despite concerns raised by experts,” committee leaders said in a letter.
Published: September 2, 2021 at 05:04PM
from NYT Health https://ift.tt/3gWhw6I
The agency approved Biogen’s Aduhelm “despite concerns raised by experts,” committee leaders said in a letter.
Published: September 2, 2021 at 05:04PM
from NYT Health https://ift.tt/3gWhw6I